| Neutrophils | Lymphocytes | Monocytes | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Variables | Low (N = 838) | High (N = 843) | P value | Low (N = 836) | High (N = 845) | P value | Low (N = 821) | High (N = 860) | P value | |
Age (years) | <  60 | 411 (49%) | 412 (48.9%) | 0.149 | 389 (46.5%) | 434 (51.4%) | 0.051 | 391 (47.6%) | 432 (50.2%) | 0.305 |
≥ 60 | 427 (51%) | 431 (51.1%) |  | 447 (53.5%) | 411 (48.6%) |  | 430 (52.4%) | 428 (49.8%) |  | |
Gender | Female | 212 (25.3%) | 134 (15.9%) | < 0.001 | 201 (24%) | 145 (17.2%) | 0.001 | 247 (30.1%) | 99 (11.5%) | < 0.001 |
Male | 626 (74.7%) | 709 (84.1%) | Â | 635 (76%) | 700 (82.8%) | Â | 574 (69.9%) | 761 (88.5%) | Â | |
Alcohol | No | 418 (49.9%) | 397 (47.1%) | 0.262 | 463 (55.4%) | 352 (41.7%) | < 0.001 | 468 (57%) | 347 (40.3%) | < 0.001 |
Yes | 420 (50.1%) | 446 (52.9%) | Â | 373 (44.6%) | 493 (58.3%) | Â | 353 (43%) | 513 (59.7%) | Â | |
Smoking | No | 499 (59.5%) | 442 (52.4%) | 0.004 | 540 (64.6%) | 401 (47.5%) | < 0.001 | 534 (65%) | 407 (47.3%) | < 0.001 |
Yes | 339 (40.5%) | 401 (47.6%) | Â | 296 (65.4%) | 444 (52.5%) | Â | 287 (35%) | 453 (52.7%) | Â | |
Etiology (HBV) | No | 326 (38.9%) | 316 (37.5%) | 0.581 | 311 (37.2%) | 331 (39.2%) | 0.422 | 256 (31.2%) | 386 (44.9%) | < 0.001 |
Yes | 512 (61.1%) | 527 (62.5%) | Â | 525 (62.8%) | 514 (60.8%) | Â | 565 (68.8%) | 474 (55.1%) | Â | |
Tumor size (cm) | <  3.2 | 491 (58.6%) | 285 (33.8%) | < 0.001 | 374 (44.7%) | 402 (47.6%) | 0.260 | 452 (55.1%) | 324 (33.7%) | < 0.001 |
≥ 3.2 | 347 (41.4%) | 558 (66.2%) |  | 462 (55.3%) | 443 (52.4%) |  | 369 (44.9%) | 536 (62.3%) |  | |
Tumor number | Single | 570 (68%) | 583 (69.2%) | 0.686 | 565 (67.6%) | 588 (69.6%) | 0.401 | 574 (69.9%) | 579 (67.3%) | 0.270 |
Multiple | 268 (32%) | 260 (30.8%) | Â | 271 (32.4%) | 257 (30.4%) | Â | 247 (30.1%) | 281 (32.7%) | Â | |
Vascular invasion | No | 743 (88.7%) | 625 (74.1%) | < 0.001 | 643 (79.9%) | 725 (85.8%) | < 0.001 | 702 (85.5%) | 666 (77.4%) | < 0.001 |
Yes | 95 (11.3%) | 218 (25.9%) | Â | 193 (23.1%) | 120 (14.2%) | Â | 119 (14.5%) | 194 (22.6%) | Â | |
Extrahepatic metastases | No | 813 (97%) | 732 (86.8%) | < 0.001 | 758 (90.7%) | 787 (93.1%) | 0.073 | 778 (94.8%) | 767 (89.2%) | < 0.001 |
Yes | 25 (3%) | 111 (13.2%) | Â | 78 (9.3%) | 58 (6.9%) | Â | 43 (5.2%) | 93 (10.8%) | Â | |
Underlying cirrhosis | No | 90 (10.7%) | 160 (19%) | < 0.001 | 90 (10.8%) | 160 (18.9%) | < 0.001 | 106 (12.9%) | 144 (16.7%) | 0.024 |
Yes | 748 (89.3%) | 683 (81%) | Â | 746 (89.2%) | 685 (81.1%) | Â | 715 (87.1%) | 716 (83.3%) | Â | |
AFP (ng/mL)a | <  100 | 520 (62.1%) | 464 (55%) | 0.014 | 450 (53.8%) | 534 (62.8%) | < 0.001 | 500 (60.9%) | 484 (56.3%) | 0.347 |
≥ 100 | 271 (32.3%) | 313 (37.1%) |  | 321 (38.4%) | 263 (31.1%) |  | 282 (34.3%) | 302 (35.1%) |  | |
PIVKA-II (mAU/L)b | <  100 | 344 (41.1%) | 230 (27.3%) | < 0.001 | 255 (30.5%) | 319 (37.8%) | 0.144 | 334 (40.7%) | 240 (27.9%) | < 0.001 |
≥ 100 | 205 (24.5%) | 310 (36.8%) |  | 252 (30.1%) | 263 (31.1%) |  | 222 (27%) | 293 (34.1%) |  |